Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the effects on contrast sensitivity (CS) measurements of intravitreal bevacizumab
injections associated with standard metabolic control in eyes with diabetic macular edema
(DME) associated with standard metabolic control.